Mark Levick

Mark Levick

Plus aucun poste en cours
62 ans
Health Technology
Consumer Services
Commercial Services

Profil

Mark Levick served as Global Head-Development at Sandoz Biopharmaceuticals from 2016 to 2019.
Dr. Levick was Chief Executive Officer at Alvotech from 2019 to 2023.
Dr. Levick was Chief Executive Officer & Director at InterAx Biotech AG from 2023 to 2025.
Dr. Levick was Chief Executive Officer at Alvotech hf.
Dr. Levick was Global Head at Novartis AG.
Dr. Levick earned a doctorate from the University of Cambridge and completed undergraduate studies at The University of Newcastle.

Anciens postes connus de Mark Levick

SociétésPosteFin
Directeur Général 17/10/2025
ALVOTECH Directeur Général 01/01/2023
Sandoz Biopharmaceuticals
Corporate Officer/Principal 01/01/2019
NOVARTIS AG Corporate Officer/Principal 01/07/2016
Directeur Général -
Voir l'expérience en détail de Mark Levick

Formation de Mark Levick

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

18

Relations au 1er degré

7

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées7

Health Technology

Consumer Services

Consumer Services

Health Technology

Commercial Services

Health Technology

Sandoz Biopharmaceuticals

  1. Bourse
  2. Insiders
  3. Mark Levick